Impact of FDA MoCRA on Chinese Cosmetics Factories & Brands
Detailed analysis of the U.S. Modernization of Cosmetics Regulation Act (MoCRA) clauses, covering facility filing, listing, and US Agent requirements.
Under MoCRA, all cosmetics exported to the US face mandatory requirements: foreign facilities must register with the FDA (requiring a U.S. Resident Agent); all product formulations and labels must be listed; and brands must keep safety substantiation records. Violations result in border detentions or Amazon take-downs.
1. Applicability & Scope
Applies to all domestic and foreign facilities manufacturing or processing cosmetics for distribution in the U.S., and their responsible persons. Small businesses with average annual gross sales of cosmetics in the U.S. under $1,000,000 for the past 3 years are exempt from facility registration and product listing, except for facilities producing eye cosmetics, injectables, lip products, or talc products.
2. Regulatory Basis & Standards
Based directly on the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), which was signed into U.S. federal law and comprehensively overhauls Chapter VI of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
3. Common Industry Misconceptions
Common myths: First, assuming "the U.S. importer can automatically act as the U.S. Agent for registration without formal mandate". Foreign facilities must designate a resident U.S. Agent with a physical address. Second, believing that "writing ingredients is enough for product listing". Listings must be formally submitted on Cosmetics Direct to receive a Product Listing Number, with warning statements updated.
4. Required Documents Checklist
Before starting MoCRA files organization, prepare the following dossier components:
- Factory FEI (FDA Establishment Identifier) number
- Signed and notarized U.S. Agent appointment agreement
- Complete formulation list showing specific INCI names and percentage concentrations
- Outer packaging artwork PDF showing compliant INCI sequences and allergen disclosures
- Toxicological and exposure data packet establishing safety substantiation
5. How QTC Can Support
QTC provides gap audits, formula review, label pre-audits, and portal submission coaching, while helping brands connect with qualified U.S. agent resources so MoCRA registration, product listing, labels, and communication files are prepared clearly.
6. Project Timeline & Process
Timeline: 1. Evaluate business size and exemption status; 2. Support FEI requests and U.S. Agent setup; 3. Cross-reference formulations with FDA prohibited/restricted lists; 4. Coach on Cosmetics Direct facility filings and listing submissions; 5. Organize and lock safety substantiation dossiers.
7. Official Sources & Last Modified
Sources: U.S. Food and Drug Administration (FDA) MoCRA portal, Cosmetics Direct User Guides, and Federal Register notices regarding cosmetics regulation updates. Content verified as of June 2026.
8. Professional Review Team Profile
Reviewed by the QTC U.S. Regulatory Affairs Division (specializing in U.S. FDA drug and cosmetic compliance) in Washington, D.C., in collaboration with the domestic export cosmetics supply chain technical team.
FAQ
What is a U.S. Agent, and what should be prepared before registration?+
A U.S. Agent is a legally required U.S. resident individual or corporate entity. The FDA contacts the agent for regulatory matters or inspection notifications. Before registration, companies should align agent details, communication procedures, facility information, product listings, and labels; QTC can help coordinate qualified U.S. agent resources and prepare submission files.
Next steps
If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.
